Strategy · public leadership · advocacy

Leadership for difficult public problems

Bella leads complex programmes, advises senior decision-makers and turns evidence into policy, funding and action.

Her career spans investment banking, strategy consulting, health-system reform, national public-health leadership and parliamentary politics. She works best where the issue is difficult, the institutions are fragmented and progress depends on bringing people with you.

Founder and Director, Pathway Analytics · 30 years across corporate, government, health and public life
Portrait of Bella Grant
BELLA GRANT · PATHWAY ANALYTICS
The route

Finance, strategy, government and politics

Senior and hands-on at every stage.

1995–2009
Investment Banking & Strategy Consulting
Vice President, Goldman Sachs; Associate Director, WestLB Panmure, leading an international equity-research team; Senior Strategy Consultant, Cap Gemini Ernst & Young.
2009–present
Founder & Director, Pathway Analytics
Built and led an independent consultancy delivering national funding reform, system reviews, service redesign and public-value analysis across government and healthcare.
2020–2022
COVID-19 public health response
Moved from frontline tracing into leadership of a multidisciplinary public-health analytics team, supporting local action and cross-government policy decisions.
2023–2024
Parliamentary Candidate
Built a general-election campaign from scratch in six weeks, recruited and led volunteers, raised more than £7,000 in grassroots funding and secured 9,533 votes.
Now
Board, Executive & Public Leadership
Strategy, programme leadership, policy, advocacy and system reform for public bodies, funders, boards and mission-led organisations.

Where Bella adds most value

At the level of the decision, the institution and the public argument: leading important programmes, advising senior teams and representing issues that matter.

01

Strategic programme leadership

Leading complex and politically sensitive work through uncertainty, organisational tension and change, setting direction, building capable teams and maintaining delivery.

02

Board, executive & policy advisory

Helping senior leaders make difficult decisions about strategy, funding, governance, delivery and public value, including programme reset and independent review.

03

Advocacy & public communication

Turning complex and contested evidence into a clear argument that ministers, boards, journalists, professionals and the public can understand and act upon.

Underpinned by: deep expertise in economics, finance, public health, data and service design. These are tools in the kit, not the limit of the role.
30 years
Operating across corporate, consulting, government, health and politics
£50m+
Reported savings associated with the wider sexual-health service redesign
43 SARCs
National review spanning more than 100 voluntary-sector organisations
9,533
Votes in a new parliamentary constituency after a six-week campaign

Leadership in action

Consistent evidence of the same strengths across very different settings: solving difficult problems, leading teams and coalitions, and turning evidence into action.

Political leadership · public speaking · mobilisation

Parliamentary Candidate, Fareham & Waterlooville

Built an entire general-election campaign from scratch in six weeks: recruited and led a volunteer team, established the public message, organised events and hustings, secured media coverage and raised more than £7,000 in grassroots donations.

Stood against Suella Braverman, the sitting MP and former Home Secretary, and used the campaign to argue publicly for health equity, accountable government and a less divisive politics.

Result 9,533 votes, a 19% share in a newly formed constituency, and clear evidence of the ability to lead, speak and persuade in public under pressure.
Corporate leadership · due diligence · transformation

Investment Banking & Strategy Consulting

Led an international Aerospace & Defence equity-research team, working directly with company boards and global fund managers. At Goldman Sachs, managed a 50-person FX operations team, with responsibility across wider functions involving more than 100 people during the financial crisis. Led major pricing, transformation, benefits-realisation and due-diligence work across FTSE 100 and FTSE 250 businesses.

Projects included a £400 million automotive redesign case, a telecoms transformation identifying £20 million-plus savings and £150 million of modelled EBITDA benefit, and a takeover due-diligence stream whose findings were pivotal to the bidder withdrawing.

Value Deep understanding of corporate strategy, capital, commercial incentives and the standard of evidence required for high-value decisions.
National crisis leadership · policy · grassroots diagnosis

COVID-19: from the frontline to cross-government strategy

Stepped into the pandemic response as a Clinical Contact Tracer, completing nearly 1,000 hours on the frontline and compiling a detailed review of failures in the national tracing pathway. The findings were escalated through personal and professional networks into senior national leadership.

She then led a multidisciplinary public-health analytics team within the Joint Biosecurity Centre / UKHSA, bringing epidemiologists, data scientists, product specialists and policy users together. The team supported local outbreak action and cross-government work on the opening-up roadmap, containment policy and sectors including nightclubs.

Leadership Joined grassroots evidence, scientific analysis and national policy, while rebuilding team structure, morale and delivery in an intense new organisation.
National funding reform · coalition building · implementation

Integrated Sexual Health Tariff

Led a long-running reform programme to replace fragmented and inequitable payment arrangements with an integrated pathway-based funding model. The work had to survive competing institutional interests, structural inertia and the transfer of sexual-health commissioning from the NHS to local authorities.

Built agreement among clinicians, commissioners, providers and government stakeholders; led the design, road-testing and implementation; and ensured the model could be adopted through a practical web solution rather than remaining a policy document.

Outcome Nationally used funding infrastructure, improved transparency and integration incentives, and reported system savings of more than £50 million.
London-wide system review · health equity · public voice

UN AIDS Fast-Track Cities Initiative, London

Led London's assets, gaps and opportunities review against the international HIV goals. The work combined more than 120 interviews, service-user storytelling, quantitative evidence and health-economic analysis across clinical services, commissioners, local government, national bodies and community organisations.

A central part of the work was surfacing issues that conventional performance measures could miss, including stigma, inequality and the lived experience of people using services, and carrying those findings into senior decision-making.

Outcome A major system report and recommendations for the Mayor of London, NHS England, Public Health England and London Councils.
Cross-government negotiation · sensitive systems

National Sexual Assault Services Review

Co-led national work across NHS England, the Ministry of Justice and the Home Office where responsibilities, funding and institutional interests had stalled progress. Worked with 43 Sexual Assault Referral Centres and more than 100 voluntary-sector organisations to map pathways, costs, workforce and failure points.

Translated detailed frontline evidence into a framework senior decision-makers could use to negotiate responsibility and funding across organisational boundaries.

Outcome Supported a clearer cross-government responsibility matrix, new funding agreements and a more coherent operating model.
Current direction

From technical consultancy to public leadership

Bella continues to lead complex evaluation and health-system work, including equitable access to HIV prevention. Her next chapter is deliberately broader: think-tank and policy leadership, independent review, programme direction, advocacy, chairing and public communication.

Focus Roles where experience, judgement, communication and the ability to lead across institutions matter more than producing another model at a desk.
Speaking, advocacy & facilitation

Making the case and building agreement

Bella has spent her career explaining complex and contested issues in rooms where decisions have to be made. Her experience ranges from political hustings and media interviews to board, policy and investor presentations, and the chairing of multi-stakeholder workshops.

She brings together different perspectives, makes the evidence clear and helps a group reach a practical course of action.

About Bella

Experience across every side of the decision

Bella Grant is the founder and director of Pathway Analytics. She began her career in corporate finance and equity research before moving into strategy consulting, health-system reform and government public-health leadership.

Across each decade of her career she has led substantial programmes: corporate transformation and due diligence; national funding and service reform; London-wide HIV strategy; the COVID-19 response; and, in 2024, a parliamentary campaign built from scratch.

Her particular strength is operating between worlds, finance and public value, evidence and politics, frontline experience and senior decision-making, and bringing them into a coherent direction.

MBA, London Business School, including exchange at Kellogg School of Management · BA History, Durham University · Diploma in Business French, King's College London.

Bella publishes and works professionally as Bella Grant. Earlier publications may also appear under Arabella Grant.

Pathway Analytics

Contact

To discuss a project with Bella or the wider Pathway Analytics team, please get in touch.

Contact Pathway Analytics
Bella Grant
Founder & Director, Pathway Analytics
bella@pathwayanalytics.com
pathwayanalytics.com
United Kingdom